Bath & Body Works (BBWI) CEO granted 212,993 restricted stock units

Rhea-AI Filing Summary

Heaf Daniel reported acquisition or exercise transactions in this Form 4 filing.

Bath & Body Works, Inc. reported that CEO Daniel Heaf received an equity award of 212,993 shares of common stock at no purchase price as part of his compensation. These shares are in the form of restricted stock units that vest over three years: 30% on the first anniversary of the March 12, 2026 grant date, 30% on the second anniversary, and 40% on the third anniversary. Following this grant, Heaf directly holds 295,583 shares of Bath & Body Works common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heaf Daniel

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OH 43230

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	03/12/2026		A		212,993(1)	A	$0.0000	295,583	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date.

	Robert J. Tannous, Attorney-in-Fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Bath & Body Works (BBWI) report for CEO Daniel Heaf?

Bath & Body Works reported that CEO Daniel Heaf received a grant of 212,993 shares of common stock as an equity award. The award was made at no purchase price and structured as restricted stock units subject to multi-year vesting conditions.

How many Bath & Body Works (BBWI) shares did the CEO hold after this Form 4 grant?

After the equity award, CEO Daniel Heaf directly held 295,583 shares of Bath & Body Works common stock. This total reflects the newly granted 212,993 restricted stock units added to his prior holdings, as disclosed in the Form 4 filing.

What is the vesting schedule for the Bath & Body Works (BBWI) CEO’s restricted stock grant?

The CEO’s restricted stock units vest 30% on the first anniversary of the March 12, 2026 grant date, 30% on the second anniversary, and 40% on the third anniversary. This three-year schedule ties the award to ongoing service and performance.

Was the Bath & Body Works (BBWI) CEO’s Form 4 transaction an open-market stock purchase?

No, the CEO’s Form 4 transaction was not an open-market purchase. It was a grant of 212,993 restricted stock units at a price of $0.00 per share, reflecting a compensation-related award rather than a voluntary buy in the market.

Does the Bath & Body Works (BBWI) CEO’s Form 4 show any derivative securities like options?

The Form 4 data provided does not list any derivative security transactions for CEO Daniel Heaf. It shows only a non-derivative equity award of common stock through restricted stock units, with no options or other derivatives reported in this filing.